Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 43M | 36M | 30M | 35M | 29M | 28M |
| Cost of revenue | 12M | 13M | 10M | 10M | 10M | 9M |
| Gross profit | 30M | 23M | 20M | 25M | 20M | 19M |
| Research and development | 2M | 1M | 1M | 2M | 2M | 2M |
| Selling, general and administrative | 13M | 12M | 11M | 12M | 10M | 10M |
| Operating expenses | 28M | 27M | 25M | 27M | 23M | 23M |
| Operating income | 2M | −3M | −5M | −2M | −4M | −4M |
| Pre-tax income | 769,000 | −5M | −5M | −2M | −4M | −4M |
| Income tax | 144,000 | 367,000 | 843,000 | 291,000 | 170,000 | 231,000 |
| Net income | 625,000 | −5M | −6M | −2M | −4M | −4M |
| Earnings per share | 0.02 | −0.19 | −0.22 | −0.09 | −0.15 | −0.17 |
| Earnings per share, diluted | 0.02 | −0.19 | −0.22 | −0.09 | −0.15 | −0.17 |
| Weighted average shares | 28M | 28M | 27M | 27M | 26M | 26M |
| Weighted average shares, diluted | 29M | 28M | 27M | 27M | 26M | 26M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 19M | 25M | 22M | 66M | 14M | 21M | 11M | 21M |
| Receivables | 13M | 16M | 15M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 3M | — | — | 2M | — | — |
| Depreciation and amortisation | 7M | — | — | 6M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 14M |
| 16M |
| 18M |
| 17M |
| 16M |
| Inventory | 3M | 3M | 2M | 142,000 | 220,000 | 195,000 | 233,000 | 263,000 |
| Current assets | 259M | 278M | 193M | 300M | 293M | 237M | 227M | 232M |
| Property, plant and equipment | 30M | 28M | 26M | 23M | 21M | 20M | 18M | 17M |
| Goodwill | 116M | 116M | 116M | 95M | 95M | 95M | 95M | 9M |
| Total assets | 519M | 531M | 447M | 506M | 499M | 437M | 428M | 420M |
| Current liabilities | 246M | 260M | 178M | 235M | 284M | 224M | 212M | 209M |
| Total liabilities | 319M | 334M | 254M | 311M | 301M | 239M | 229M | 225M |
| Equity | 200M | 198M | 193M | 194M | 198M | 197M | 199M | 196M |
| Shares outstanding | 29M | 28M | 28M | 27M | 27M | 27M | 27M | 26M |
| Shares issued | 29M | 28M | 28M | 27M | 27M | 27M | 27M | 26M |
| Treasury shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| — |
| — |
| Share-based compensation | 2M | 2M | 2M | 2M | 2M | 1M |
| Capital expenditure | 218,000 | — | — | 192,000 | — | — |
| Investing cash flow | −5M | — | — | −13M | — | — |
| Financing cash flow | −12M | — | — | 64M | — | — |